Easywell Biomedicals, Inc.

Summary

Easywell Biomedicals, Inc., a biopharmaceutical and medical device company, develops and commercializes medical devices, drug substances, and pharmaceutical dosage forms in Taiwan and internationally. The company is developing TLX-001, an anti-cough medicine; TLX-005, an anti-urinary incontinence medicine; TLX-006 for treatment of breast cancer in PMS women; TLX-007 and TLX-004, an anti-depressant; TLX-008 for prevention of pneumocystis pneumonia; TLX-012 for treatment of epilepsy; TLX-017 for treatment of chronic angina; and TLX-011 for treatment of inflammatory lesions of rosacea. It also develops TWB-201 for Parkinson patch; TLX-501, an urinary medicine; and TLX-502, a pneumonia medicine. It also provides medical devices, including digital clinical thermometers, infrared ear thermometers, and transcutaneous electrical nerve stimulation products for pain relief. The company was formerly known as Actherm Inc. and changed its name to Easywell Biomedicals, Inc. in July 2015. Easywell Biomedicals, Inc. was incorporated in 1998 and is headquartered in Hsinchu City, Taiwan.